- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/37 - Papovaviridae, p. ex. virus du papillome, virus du polyome, SV 40
Détention brevets de la classe C12N 15/37
Brevets de cette classe: 128
Historique des publications depuis 10 ans
|
2
|
8
|
3
|
14
|
3
|
19
|
6
|
5
|
10
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Sinocelltech Ltd. | 77 |
14 |
| The Trustees of the University of Pennsylvania | 4289 |
10 |
| Xiamen University | 530 |
9 |
| Beijing Health Guard Biotechnology, Inc. | 11 |
8 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 105 |
6 |
| Xiamen Innovax Biotech Co., Ltd. | 88 |
5 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 28 |
4 |
| Becton, Dickinson and Company | 7211 |
3 |
| Inovio Pharmaceuticals, Inc. | 317 |
3 |
| The Regents of the University of California | 19780 |
2 |
| Bioleaders Corporation | 59 |
2 |
| British Columbia Cancer Agency Branch | 193 |
2 |
| Daiichi Sankyo Company, Limited | 1848 |
2 |
| National Institutes of Biomedical Innovation, Health and Nutrition | 155 |
2 |
| Riken | 1687 |
2 |
| University of Cape Town | 259 |
2 |
| Synplogen Co., Ltd. | 25 |
2 |
| ISA Pharmaceuticals B.V. | 2 |
2 |
| The General Hospital Corporation | 4695 |
1 |
| Anaconda Pharma | 5 |
1 |
| Autres propriétaires | 46 |